Cardiac Autonomic Neuropathy (CAN)in type-1 diabetes mellitus patients and its association with the duration of disease and glycemic control

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 4, 2009, Pages 232-235

  Khoharo, Haji Khan ^a,d   Ansari, Shuaib ^b   Shaikh, Imran Ali ^c   Qureshi, Fatima ^c  

^a Muhammad Medical College Mirpurkhas   (Pakistan)

^b Liaquat University Eye Hospital   (Pakistan)

^c ISRA UNIVERSITY   (Pakistan)

^d NONE   (Pakistan)

Author keywords

Cardiac autonomic neuropathy; Resting tachycardia; Sinus arrhythmia; Valsalva maneuver

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CARDIAC AUTONOMIC NEUROPATHY; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIARRHEA; DISEASE DURATION; ELECTROCARDIOGRAPHY; FEMALE; GLYCEMIC CONTROL; HEART RATE VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERHIDROSIS; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ORTHOSTATIC HYPOTENSION; QT INTERVAL; RR INTERVAL; SINUS ARRHYTHMIA; STOMACH PARESIS; TACHYCARDIA; VALSALVA MANEUVER;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PAKISTAN; RESPIRATORY RATE; RISK FACTORS; TIME FACTORS;

EID: 65749115022     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wild S, Green A, Sicree R, King H, Roglic G. Global prevalence of diabetes: estimates for the 2000 and projections for the 2030. Diabetes Care 2004; 27:1047-53.
2. Pakistan Medical Research Council. National Health Survey of Pakistan 1990-94. Health profile of people of Pakistan. Islamabad: PMRC; 1998:p.54-6.
3. Shera AS, Rafique G, Khwaja IA, Ara J, Baqai S, King H. Pakistan national diabetes survey. Prevalence of glucose intolerance and associated factors in Shikarpur, Sindh Province. Diabet Med 1995; 12:1116-21.
4. Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician 2005; 71:2123-8.
5. Zeigler D, Gries FA, Muhlen H, Rathmann W, Spuler M, Lessmann F. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes center. The Dia CAN Multicenter Study Group. Diabetes Metab 1993; 19:143-51.
6. Albright AL. Exercise precautions and recommendations for patients with autonomic neuropathy. Diabetes Spectrum 1998; 11: 231-7.
7. Maser RE. Autonomic neuropathy: patient care. Diabetes Spectrum 1998; 11:224-7.
8. Vinik AL, Mitchell BD, Leicher SB, Wagner AL, O' Brian JT, Georges LP. Epidemiology of the complications of diabetes. In: Leslie RDG, Robbins DC, (edi). Diabetes: clinical sciences in practice. Cambridge: Cambridge University Press; 1995:p.221-87.
9. The diabetes control and complications trial research group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998; 41:416-23.
10. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 2001; 68:928-30, 932, 934-44.
11. Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Hather JB, Ensinck JW, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 1984; 7:447-53.
12. Zeigler D, Gries FA, Spuler M, Lessmann F. The epidemiology of diabetic neuropathy: diabetic cardiovascular autonomic neuropathy multicenter study group. J Diabetes ComplIcations 1992; 6:49-57.
13. Jermendy G, Toth L, Voros P, Kiraly M, Perenyr J, Kammerer L, et al. Impairment of cardiorespiratory reflexes and its association with distal somatic neuropathy in diabetic patients free from clinical symptoms of autonomic neuropathy. Exp Clin Endocrinol 1990; 96:199-206.
14. Chanudet X, Rabasa R, Chau NP, Bauduceau B, Garcin JM, Gautier D, et al. Comparative evaluation of diabetic cardiac autonomic neuropathy by spectrum analysis and ewing's test. Arch Mal Coeur Vaiss 1993; 86:1143-8.
15. Hasslacher C, Bassler G, Wahl P, Hurm M. Cardiac autonomic neuropathy in diabetics, study on incidence, pathogenesis and prognosis. Fortschr Med 1982; 100:1059-62.
16. Kennedy WR, Navarro X, Sutherland DE. Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 1995; 45:773-80.
17. The effect of intensive diabetes therapy on the development and progression of neuropath. The diabetes control and complication trial research group. Ann Intern Med 1995; 122: 561-8.
18. Burak W, Gerzeszczak W, Bujak Rosenbeiger E. Diagnosis of diabetic autonomic neuropathy in young patients with Diabetes mellitus type I. Pol Arch Med Wewn 2000; 103:235-9.
19. Jermendy G, Toth L, Voros P, Perenyi J, Kammerer L, Pogatsa G, et al. Prospective study of cardiac autonomic neuropathy in diabetes mellitus. Orv Hetil 1991; 132:1351-2, 1355-8.
20. Jalal S, Alai MS, Khan KA, Jan VM, Rhather RA, Iqbal K, et al. Silent myocardial ischemia and cardiac autonomic neuropathy in diabetics. J Assoc Physicians India 1999; 47:767-9.
21. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980; 49:95-108.